These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37873426)

  • 1. Benchmarking AlphaMissense Pathogenicity Predictions Against Cystic Fibrosis Variants.
    McDonald EF; Oliver KE; Schlebach JP; Meiler J; Plate L
    bioRxiv; 2024 Jan; ():. PubMed ID: 37873426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benchmarking AlphaMissense pathogenicity predictions against cystic fibrosis variants.
    McDonald EF; Oliver KE; Schlebach JP; Meiler J; Plate L
    PLoS One; 2024; 19(1):e0297560. PubMed ID: 38271453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the pathogenicity of CFTR missense variants: Multiple comparisons of in silico predictors and variant annotation databases.
    Michels M; Matte U; Fraga LR; Mancuso ACB; Ligabue-Braun R; Berneira EFR; Siebert M; Sanseverino MTV
    Genet Mol Biol; 2019; 42(3):560-570. PubMed ID: 31808782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis of Rwandan patients with cystic fibrosis-like symptoms: identification of novel cystic fibrosis transmembrane conductance regulator and epithelial sodium channel gene variants.
    Mutesa L; Azad AK; Verhaeghe C; Segers K; Vanbellinghen JF; Ngendahayo L; Rusingiza EK; Mutwa PR; Rulisa S; Koulischer L; Cassiman JJ; Cuppens H; Bours V
    Chest; 2009 May; 135(5):1233-1242. PubMed ID: 19017867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic Fibrosis.
    McCague AF; Raraigh KS; Pellicore MJ; Davis-Marcisak EF; Evans TA; Han ST; Lu Z; Joynt AT; Sharma N; Castellani C; Collaco JM; Corey M; Lewis MH; Penland CM; Rommens JM; Stephenson AL; Sosnay PR; Cutting GR
    Am J Respir Crit Care Med; 2019 May; 199(9):1116-1126. PubMed ID: 30888834
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure and function of the cystic fibrosis transmembrane conductance regulator.
    Morales MM; Capella MA; Lopes AG
    Braz J Med Biol Res; 1999 Aug; 32(8):1021-8. PubMed ID: 10454765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.
    Parad RB; Gerard CJ; Zurakowski D; Nichols DP; Pier GB
    Infect Immun; 1999 Sep; 67(9):4744-50. PubMed ID: 10456926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Assays Are Essential for Interpretation of Missense Variants Associated with Variable Expressivity.
    Raraigh KS; Han ST; Davis E; Evans TA; Pellicore MJ; McCague AF; Joynt AT; Lu Z; Atalar M; Sharma N; Sheridan MB; Sosnay PR; Cutting GR
    Am J Hum Genet; 2018 Jun; 102(6):1062-1077. PubMed ID: 29805046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of AlphaMissense data in different protein groups and structural context.
    Tordai H; Torres O; Csepi M; Padányi R; Lukács GL; Hegedűs T
    Sci Data; 2024 May; 11(1):495. PubMed ID: 38744964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missense variants in CFTR nucleotide-binding domains predict quantitative phenotypes associated with cystic fibrosis disease severity.
    Masica DL; Sosnay PR; Raraigh KS; Cutting GR; Karchin R
    Hum Mol Genet; 2015 Apr; 24(7):1908-17. PubMed ID: 25489051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway.
    Eidelman O; Srivastava M; Zhang J; Leighton X; Murtie J; Jozwik C; Jacobson K; Weinstein DL; Metcalf EL; Pollard HB
    Mol Med; 2001 Aug; 7(8):523-34. PubMed ID: 11591888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA sequencing analysis of cystic fibrosis transmembrane conductance regulator gene identifies cystic fibrosis-associated variants in the Severe Asthma Research Program.
    Izquierdo ME; Marion CR; Moore WC; Raraigh KS; Taylor-Cousar JL; Cutting GR; Ampleford E; Hawkins GA; Zein J; Castro M; Denlinger LC; Erzurum SC; Fahy JV; Israel E; Jarjour NN; Mauger D; Levy BD; Wenzel SE; Woodruff P; Bleecker ER; Meyers DA; Ortega VE
    Pediatr Pulmonol; 2022 Jul; 57(7):1782-1788. PubMed ID: 35451201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Pathogenic Variant of the
    Arslan AB; Zamani AG; Pekcan S; Yıldırım MS
    J Pediatr Genet; 2020 Mar; 9(1):40-43. PubMed ID: 31976142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign outcome among positive cystic fibrosis newborn screen children with non-CF-causing variants.
    Salinas DB; Sosnay PR; Azen C; Young S; Raraigh KS; Keens TG; Kharrazi M
    J Cyst Fibros; 2015 Nov; 14(6):714-9. PubMed ID: 25824995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses.
    Sosnay PR; Salinas DB; White TB; Ren CL; Farrell PM; Raraigh KS; Girodon E; Castellani C
    J Pediatr; 2017 Feb; 181S():S27-S32.e1. PubMed ID: 28129809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete CFTR gene sequencing in 5,058 individuals with cystic fibrosis informs variant-specific treatment.
    Raraigh KS; Aksit MA; Hetrick K; Pace RG; Ling H; O'Neal W; Blue E; Zhou YH; Bamshad MJ; Blackman SM; Gibson RL; Knowles MR; Cutting GR
    J Cyst Fibros; 2022 May; 21(3):463-470. PubMed ID: 34782259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How the sweat gland reveals levels of CFTR activity.
    Wine JJ
    J Cyst Fibros; 2022 May; 21(3):396-406. PubMed ID: 35184981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal CFTR missense variants severely affect the behavior of the CFTR chloride channel.
    Gené GG; Llobet A; Larriba S; de Semir D; Martínez I; Escalada A; Solsona C; Casals T; Aran JM
    Hum Mutat; 2008 May; 29(5):738-49. PubMed ID: 18306312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.